ClinicalTrials.gov
ClinicalTrials.gov Menu

Stress, Coping and Health Behaviors in Pregnancy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02705235
Recruitment Status : Completed
First Posted : March 10, 2016
Last Update Posted : March 30, 2017
Sponsor:
Information provided by (Responsible Party):
Crystal Epstein, University of Nebraska

Brief Summary:
Stress is an important determinant of pregnancy health behaviors, maternal physiology and maternal-infant health outcomes. The purpose of this study is to explain the relationship between dimensions of lifetime stress and the stress hormone cortisol in pregnant women. Additionally, the study will examine how coping styles help pregnant women to better manage stress and improve their health behaviors to achieve the goal of having a healthy baby.

Condition or disease
Pregnancy Stress Coping Health Behaviors

Detailed Description:

Health behaviors are important modifiable factors for promoting maternal-infant health during pregnancy, and include behaviors such as diet, exercise, and avoidance of harmful substances. During pregnancy, women are often motivated to improve their lifestyle to achieve positive pregnancy outcomes; however, they may struggle to do so because certain behaviors such as excessive eating, smoking and drinking have become a means for coping with stress. Stress prior to and during pregnancy negatively impacts birth outcomes via complex behavioral and physiologic pathways. From a behavioral perspective, stress diminishes women's engagement in positive health behaviors during pregnancy. From a physiologic perspective, stress affects the regulation of cortisol, a hormone involved in fetal development and timing of delivery. Women use various coping styles to manage stress. It is unknown, however, whether certain coping styles attenuate the negative behavioral and physiologic effects of stress on birth outcomes. Therefore, the purpose of this descriptive, cross-sectional study is to examine the influence of coping styles on stress, physiologic cortisol regulation and health behaviors in a diverse sample of pregnant women (N=55) during 24-28 weeks gestation.

A quantitative design with a qualitative arm will be used to:

  1. explain the relationship between cortisol regulation and lifetime stress,
  2. determine whether coping styles (active vs. disengaged) moderate the effect of stress on cortisol, health behaviors, and birth outcomes, and
  3. describe women's qualitative experience of stress and coping and determine the extent to which the qualitative findings converge with the quantitative findings.

Data will be collected over three prenatal visits during the second half of pregnancy, and will include self-report questionnaires, multiple salivary cortisol sampling, medical record data, a structured stress interview and a semi-structured qualitative interview in a subset of participants (n=12). This study will use an interview-based stress assessment in tandem with physiologic (i.e. cortisol) stress measures in pregnancy. Additionally, the qualitative data will provide a contextual understanding of pregnant women's stress and coping experiences. The research findings will inform the future development and testing of a psychosocial, coping-based intervention to promote positive health behaviors in pregnancy and birth outcomes. Furthermore, this training will provide a solid scientific foundation for the applicant to develop a career as an independent nurse-scientist in maternal-infant health promotion research, under the guidance of an experienced interdisciplinary team of mentors with complementary expertise in stress, coping health behavior, and pregnancy related research. The proposal is consistent with the National Institute of Nursing Research's (NINR) mission to support research that promotes health and prevents disease across the lifespan, builds the scientific foundation for clinical practice, and invests in the training of the next generation of nurse-scientists.


Study Type : Observational
Actual Enrollment : 75 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Study Start Date : January 2016
Actual Primary Completion Date : August 2016
Actual Study Completion Date : August 2016



Primary Outcome Measures :
  1. Cortisol awakening response [ Time Frame: 26 weeks gestation ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Pregnant women aged 19 to 45 years old.
Criteria

Inclusion Criteria:

  • Single intrauterine pregnancy at least 20 weeks gestation
  • Aged 19 to 45
  • Ability to read and speak English
  • Able to be reached by telephone or text most days of the week

Exclusion Criteria:

  • Receiving or referred for care in the high-risk prenatal clinic
  • Have any of the following pregnancy complications or medical issues existing prior to recruitment:

Cervical or uterine abnormalities, renal, hepatic or cardiac disorders, insulin-dependent diabetes, preeclampsia, regular oral steroid use in the month prior to data collection, congenital fetal abnormalities, active placenta previa, blood group isoimmunization, or other disorders/medication use that could affect cortisol levels

  • Regular night-shift work or reversed sleep schedule

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02705235


Locations
United States, Nebraska
Nebraska Medicine
Omaha, Nebraska, United States
Sponsors and Collaborators
University of Nebraska

Responsible Party: Crystal Epstein, Ms., University of Nebraska
ClinicalTrials.gov Identifier: NCT02705235     History of Changes
Other Study ID Numbers: 718-15-EP
First Posted: March 10, 2016    Key Record Dates
Last Update Posted: March 30, 2017
Last Verified: March 2017